Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sukumvanich

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Brachytherapy|September 21, 2020
Early outcomes after definitive chemoradiation therapy with Vienna/Venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: A single-institution experienceA Keller, J L Rodríguez-López, A K Patel, et al.
Gynecologic Oncology|July 29, 2020
Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - A single-institution studyP M Pifer, R Bhargava, A K Patel, et al.
Gynecologic Oncology|January 15, 2023
The role of adjuvant treatment for early-stage uterine clear cell carcinomasT J Orellana, A A Garrett, T R Soong, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Brachytherapy|September 21, 2020
Early outcomes after definitive chemoradiation therapy with Vienna/Venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: A single-institution experienceA Keller, J L Rodríguez-López, A K Patel, et al.
Gynecologic Oncology|July 29, 2020
Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - A single-institution studyP M Pifer, R Bhargava, A K Patel, et al.
Gynecologic Oncology|January 15, 2023
The role of adjuvant treatment for early-stage uterine clear cell carcinomasT J Orellana, A A Garrett, T R Soong, et al.
Pageof 2